Status:

UNKNOWN

Endovascular Management of Direct Carotid-cavernous Fistula

Lead Sponsor:

Sohag University

Conditions:

Carotid-Cavernous Sinus Fistula

Eligibility:

All Genders

10-75 years

Phase:

NA

Brief Summary

Carotid-cavernous fistula (CCF) refers to an aberrant arteriovenous communication between the carotid arterial system and the venous compartments of the cavernous sinus (CS) Direct CCFs are when there...

Eligibility Criteria

Inclusion

  • Patients with direct type of carotid cavernous fistula

Exclusion

  • End stage renal disease
  • haemodynamically unstable patients.
  • Patients with impaired coagulation profile.

Key Trial Info

Start Date :

November 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2024

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT06091150

Start Date

November 1 2023

End Date

May 1 2024

Last Update

November 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ahmad Tharwat

Sohag, Egypt, 28825

Endovascular Management of Direct Carotid-cavernous Fistula | DecenTrialz